The Accelerate Long Island (ALI) Seed Fund and the Long Island Emerging Technologies Fund (LIETF) announced initial investments in five Long Island-based biotech and clean energy startups. Four of the five companies each receiving $100,000 are CFB Client companies: Goddard Labs, PolyNova, SynchroPET and Traverse Biosciences. Read the full press release here.
CFB Client Company, Intensity Therapeutics, Inc. established a cooperative research and development agreement (CRADA), with the National Institute of Health?s National Cancer Institute (NCI) Vaccine Branch. Intensity Therapeutics was awarded the CRADA by the NCI to study the efficacy and mechanism of action of Intensity?s in situ chemovaccination products using in vivo models of cancer. Read the full press release here.